Alzheimer’s Disease Neuroimaging Initiative

ADNI: A review of papers published since its inception to 2013
Publications
12 August 2013
“The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is an ongoing, longitudinal, multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer’s...
Read More>

Standardization of analysis sets for reporting results from ADNI MRI data
Publications
27 October 2012
Abstract: “The Alzheimer’s Disease Neuroimaging Initiative (ADNI) three-dimensional T(1)-weighted magnetic resonance imaging (MRI) acquisitions provide a rich data set for developing and testing analysis techniques for extracting structural endpoints....
Read More>

ADNI: A review of papers published since its inception
Publications
21 November 2011
Access the full article on PubMed Title: The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception Authors: Weiner MW, Veitch DP, Aisen PS, Beckett LA,...
Read More>

ADNI: progress report and future plans.
Publications
21 May 2010
The Alzheimers Disease Neuroimaging Initiative (ADNI) beginning in October 2004, is a 6-year research project that studies changes of cognition, function, brain structure and function, and biomarkers in elderly...
Read More>

Update on the Biomarker Core of ADNI subjects
Biomarker Core
21 May 2010
Here, we review progress by the Penn Biomarker Core in the Alzheimers Disease Neuroimaging Initiative (ADNI) toward developing a pathological cerebrospinal fluid (CSF) and plasma biomarker signature for mild...
Read More>

Clinical Core of ADNI: progress and plans
Biostatistics & Clinical Cores
21 May 2010
The Clinical Core of the Alzheimers Disease Neuroimaging Initiative (ADNI) has provided clinical, operational, and data management support to ADNI since its inception. This article reviews the activities and...
Read More>

ADNI biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.
Genetics Core
20 May 2010
Abstract: The role of the Alzheimers Disease Neuroimaging Initiative Genetics Core is to facilitate the investigation of genetic influences on disease onset and trajectory as reflected in structural, functional, and...
Read More>

Update on the magnetic resonance imaging core of ADNI
Publications
10 May 2010
Functions of the Alzheimers Disease Neuroimaging Initiative (ADNI) magnetic resonance imaging (MRI) core fall into three categories: (1) those of the central MRI core laboratory at Mayo Clinic, Rochester,...
Read More>

ADNI: MRI Methods
Publications
21 April 2008
Magnetic resonance imaging (MRI), (18F)-fluorodeoxyglucose positron emission tomography (FDG PET), urine serum, and cerebrospinal fluid (CSF) biomarkers, as well as clinical/psychometric assessments are acquired at multiple time points. All...
Read More>

Data News & Spreadsheets

Data recalls have been consolidated into PET and MRI spreadsheets. The MRI and PET Core also posts updates in the News section.

MR Consolidated Recalls Spreadsheet

Contact for MRI Advisories
Contact for PET Advisories

Data Recall

Occasionally, the Quality Control Process identifies data as incorrect. We will make an attempt to contact institutions that have downloaded faulty data, however we may not always be able to notify individual investigators of these problems. Therefore it is advised that investigators using ADNI data subscribe to our email system or visit the Data News and Recalls page. To subscribe, please enter your email address, first and last name in the form above. If you do not receive a confirmation email for your subscription, please check your spam folder or contact us at webmaster@loni.usc.edu. By subscribing to ADNI News, you agree to our privacy policy.